- Home
- Life Sciences
- Pharmaceutical
- Generic Drug
- Generic Drug Analysis & Statistics in Europe Countries, August 2012 (p2)
Talk to Robyn
(866) 682 9815
Search inside this page
Publication dates
Publishers
- Global Data (9)
- Business Monitor International (15)
- Espicom Business Intelligence (11)
- MarketLine (11)
- Datamonitor (9)
-
- SeeNews - Research & Profiles (5)
- RNCOS (3)
- Euromonitor International (2)
- ICD Research (2)
- Life Science Analytics (LSA) (2)
- SCRIP Insights (2)
- Firstword Pharma (1)
- GBI Research (1)
- Global Industry Analyst (1)
- Global Markets Direct (1)
- Industry Experts (1)
All regions
- All
- Europe
- Albania (1)
- Austria (2)
- Belgium (5)
- Bulgaria (3)
- Czech Republic (6)
- France (14)
- Germany (21)
- Hungary (2)
- Iceland (1)
- Ireland (1)
- Italy (10)
- Latvia (1)
- Lithuania (1)
- Netherlands (9)
- Norway (2)
- Poland (6)
- Portugal (5)
- Romania (9)
- Russian Federation (11)
- Serbia and Montenegro (1)
- Slovakia (slovak Republic) (4)
- Slovenia (1)
- Spain (10)
- Sweden (1)
- Switzerland (4)
- Ukraine (1)
- United Kingdom (18)
- Europe
data types
Free Market Research Guides to Download
Generic Drug Analysis & Statistics in Europe Countries, August 2012 (p2)
» Purchase Premium Reports
31-60 of 67 reports
Generics: World Market Overview (Market size, Segmentation and Trends Analysis)
- $ 1 495
- Industry report
- August 2012
- by MarketLine
It includes detailed data on industry size and sector ation, textual analysis of the key trends and competitive landscape, and profiles of the leading firms . This incisive report provides expert analysis ...
- Industries : Generic Drug
- Countries : World, Europe, United States, United Kingdom, Netherlands, France, Germany, Japan, Canada, Spain, Italy, Belgium, China
Generics Market Overview in Spain
- $ 350
- Industry report
- July 2012
- by MarketLine
It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...
- Industries : Generic Drug
- Countries : Spain
Generics Market Overview in the United Kingdom
- $ 350
- Industry report
- July 2012
- by MarketLine
It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...
- Industries : Generic Drug
- Countries : United Kingdom
Generics Market Overview in the Netherlands
- $ 350
- Industry report
- July 2012
- by MarketLine
It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...
- Industries : Generic Drug
- Countries : Netherlands
Generics Market Overview in Germany
- $ 350
- Industry report
- July 2012
- by MarketLine
It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...
- Industries : Generic Drug
- Countries : Germany
Generics Market Overview in Italy
- $ 350
- Industry report
- July 2012
- by MarketLine
It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...
- Industries : Generic Drug
- Countries : Italy
Generics Market Overview in Belgium
- $ 350
- Industry report
- July 2012
- by MarketLine
It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...
- Industries : Generic Drug
- Countries : Belgium
Generics Market Overview in France
- $ 350
- Industry report
- July 2012
- by MarketLine
It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...
- Industries : Generic Drug
- Countries : France
Portugal Pharmaceuticals and Healthcare Industry Update Quarter 3 2012
- $ 1 088
- Industry report
- June 2012
- by Business Monitor International
Includes 3 FREE quarterly updates BMI View: A year has passed since the EU/IMF/ECB's rescue package was approved, and the obligations that form part of the economic adjustment programme have had, and ...
- Industries : Generic Drug
- Countries : Portugal
Inhalation & Nasal Spray Generic Drugs 2012
- $ 1 969
- Industry report
- June 2012
- by Espicom Business Intelligence
It is no surprise then, that such high revenue originator drugs are attracting interest from prospective generic competitors. Unlike the oral generics market, however, where numerous companies typically ...
- Industries : Generic Drug
- Countries : United States, United Kingdom, Europe, World
Sandoz International GmbH SWOT
- $ 175
- Company report
- June 2012
- by MarketLine
examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Sandoz, the generic business division of Novartis, ...
- Industries : Generic Drug
- Countries : Germany
Global Biosimilars Industry
- $ 4 500
- Industry report
- April 2012
- by Global Industry Analyst
This report analyzes the worldwide markets for Biosimilars in US$ Million. The report provides separate comprehensive analytics for US, Europe, and Japan. Annual estimates and forecasts are provided fo ...
- Industries : Generic Drug
- Countries : World, India, Europe, United States, Japan, France, Germany, Asia, United Kingdom, North America
Gauging the Biosimilar Effect: will the market boom or bust?
- $ 895
- Industry report
- January 2012
- by Firstword Pharma
It was supposed to be the ?epoch of biosimilars?, or drugs that copied existing biologics but had the potential to be more cost-effective. Yet five years later, biosimilars have failed to reach thei ...
- Industries : Generic Drug
- Countries : Germany, United States
Mylan - Strategic SWOT Analysis Review
- $ 250
- Company report
- December 2011
- by Global Data
Mylan, formerly known as Generics (UK) Ltd, is a supplier of generic pharmaceuticals, encompassing all the major therapeutic classes. With over 350 products in its portfolio, the company supplies ove ...
- Industries : Generic Drug
- Countries : United Kingdom
Emerging Pharmaceutical Markets Globally
- $ 1 400
- Industry report
- November 2011
- by RNCOS
The growth in pharma markets in developing countries with emerging economies (E7 countries) has outpaced the overall growth of the global pharma market. The factors including rapidly growing economies ...
- Industries : Generic Drug
- Countries : Indonesia, India, Brazil, China, Mexico, Russian Federation, World, Asia, South America
Mylan SWOT Analysis, Strategy, Revenues and Profits
- $ 250
- Company report
- September 2011
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Generic Drug
- Countries : United Kingdom
Apotex, Inc.: Company Profile and SWOT Analysis
- $ 99
- Company report
- September 2011
- by ICD Research
Synopsis ICD Research's "Apotex, Inc.: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, business ...
- Industries : Generic Drug
- Countries : Canada, Czech Republic, New Zealand, Australia, Netherlands, Mexico, Poland, Belgium, World, Europe, Oceania, North America, United Kingdom
Portugal Pharmaceuticals and Healthcare Industry Update Quarter 4 2011
- $ 1 088
- Industry report
- September 2011
- by Business Monitor International
BMI View: Portugal is typical of many Western European industries. It is mature, with little scope for growth and is subject to downward pressures on pricing and the demands of an aging population. Following ...
- Industries : Generic Drug
- Countries : Portugal
UK Generics Market Analysis
- $ 800
- Industry report
- April 2011
- by RNCOS
The UK is one of the largest economies in the world. The per capita income and spending has been also increasing for the last few years. Besides, due to the increasing consumer spending on the branded ...
- Industries : Generic Drug
- Countries : United Kingdom
Mylan (formerly Generics (UK) Limited)-Detailed Product Pipeline
- $ 750
- Company report
- March 2011
- by Life Science Analytics (LSA)
Mylan (formerly Generics (UK) Limited)-Detailed Product Pipeline provides up to date insight into company's business description, product information, pipeline details including both summary information ...
- Industries : Generic Drug
- Countries : United Kingdom
Mylan (formerly Generics (UK) Limited)-Therapeutic Competitors Report
- $ 350
- Company report
- March 2011
- by Life Science Analytics (LSA)
Mylan (formerly Generics (UK) Limited)-Therapeutic Competitors Report Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, ...
- Industries : Generic Drug
- Countries : United Kingdom
Pharmaceutical New Development 2011 - Brand Erosion Post-Patent Expiry
- $ 3 800
- Industry report
- February 2011
- by Datamonitor
About This Report Pharma is facing slowing sales growth in the developed pharmaceutical industries, driven by increasing generic competition. However, the speed and severity of brand erosion is by no means ...
- Industries : Generic Drug
- Countries : China, Australia, Spain, Russian Federation, Italy, France, Germany, Japan, World, Europe, Brazil, United States, United Kingdom, India
Gedeon Richter Generics Company Intelligence Report
- $ 341
- Company report
- January 2011
- by Espicom Business Intelligence
Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...
- Industries : Generic Drug
- Countries : Hungary
ratiopharm Generics Company Intelligence Report
- $ 341
- Company report
- January 2011
- by Espicom Business Intelligence
Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...
- Industries : Generic Drug
- Countries : Germany, Canada, Europe, Netherlands, World, North America, United Kingdom
Stada Arzneimittel Generics Company Intelligence Report
- $ 341
- Company report
- January 2011
- by Espicom Business Intelligence
Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...
- Industries : Generic Drug
- Countries : Germany
Krka Generics Company Intelligence Report
- $ 341
- Company report
- January 2011
- by Espicom Business Intelligence
Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...
- Industries : Generic Drug
- Countries : Europe, Slovenia, Germany, World, China
Ranbaxy Generics Company Intelligence Report
- $ 341
- Company report
- January 2011
- by Espicom Business Intelligence
Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...
- Industries : Generic Drug
- Countries : South Africa, Canada, India, World, Africa, United States, Romania, Japan, Mexico, Malaysia, China, North America, Asia, Europe
Sanofi-Aventis Generics Company Intelligence Report
- $ 341
- Company report
- January 2011
- by Espicom Business Intelligence
Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...
- Industries : Generic Drug
- Countries : Czech Republic, United Kingdom, Europe, Brazil, France, Germany, South America, World, Mexico, Slovakia (slovak Republic), Romania, Portugal
Actavis Generics Company Intelligence Report
- $ 341
- Company report
- January 2011
- by Espicom Business Intelligence
Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...
- Industries : Generic Drug
- Countries : United States, Europe, Iceland, Switzerland, Bulgaria, France, Germany, World, Netherlands, Norway, United Kingdom, Sweden, Spain, Russian Federation, Ireland, Austria, China, Serbia and Montenegro, North America
Egis Generics Company Intelligence Report
- $ 341
- Company report
- January 2011
- by Espicom Business Intelligence
Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...
- Industries : Generic Drug
- Countries : Hungary, Europe, Russian Federation, France, Austria, South Korea, World
» Download Public Reports
58 reports
Company Report: Generic Drug in The United States and France for Year 2012
- Company report
- May 2012
- 7 pages
- by Corporation
... A definitive agreement to acquire specialty dermatology generics company fougera pharmaceuticals. Under the terms of the agreement, novartis will acquire the business, which is based in melville, new ...
Windsor Ag - Company Report For Year 2012
October 2012Generic Drug Market In Europe
February 2013Generic Drug Business In Australia And Italy
November 2012» Read our Company Profiles
2 CompaniesGlaxoSmithKline P.L.C.
United StatesNovartis Inc.
SwitzerlandReportlinker.com © Copyright 2013. All rights reserved.
